evaluating the next steps for research in myelofibrosis
Published 4 years ago • 119 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:39
evaluating prognosis and treatment options for patients with myelofibrosis
-
2:03
evaluating prognosis and treatment options for patients with myelofibrosis
-
5:38
considerations in the assessment of myelofibrosis
-
1:12
evidence supports rechallenging of jak inhibitors in myelofibrosis
-
2:57
advances in myelofibrosis research
-
4:30
next steps for myeloma research and treatment
-
4:07
diagnosis/risk classification for primary myelofibrosis
-
4:01
treatment for primary myelofibrosis
-
3:58
primary myelofibrosis therapeutic response assessment
-
3:09
key data for the use of fedratinib in mf
-
1:00:56
taking the targeted option for myelofibrosis
-
4:14
stepping forward: future treatment of myelofibrosis
-
1:15
reviewing the role and efficacy of ruxolitinib in myelofibrosis ten years after its approval
-
12:34
optimizing outcomes of jak inhibition in myelofibrosis: practical considerations for the clinic
-
1:30:32
integrating new research information into current clinical care — myelofibrosis
-
0:51
the need for disease-modifying drugs in myelofibrosis
-
0:45
exploring fda-approved treatment options for patients with myelofibrosis
-
2:36
case 1: fedratinib treatment for myelofibrosis
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib